IO Biotech, Inc. — Director's Dealing 2021

Nov 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04

Reporting Person: Novo Holdings A/S (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
SERIES B CONVERTIBLE PREFERRED STOCK	$		COMMON STOCK (2006715)		Direct
SERIES C CONVERTIBLE PREFERRED STOCK	$		COMMON STOCK (946217)		Direct

Footnotes

F1: The shares of preferred stock convert to common stock based on a conversion ratio that takes into account interest that accrues since the date of issuance of such preferred stock and the price of the stock sold to the underwriters in the IPO.